AP2002002671A0 - Protease inhibitors. - Google Patents
Protease inhibitors.Info
- Publication number
- AP2002002671A0 AP2002002671A0 APAP/P/2002/002671A AP2002002671A AP2002002671A0 AP 2002002671 A0 AP2002002671 A0 AP 2002002671A0 AP 2002002671 A AP2002002671 A AP 2002002671A AP 2002002671 A0 AP2002002671 A0 AP 2002002671A0
- Authority
- AP
- ARIPO
- Prior art keywords
- disease
- cartilage
- compounds
- protease inhibitors
- matrix degradation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epoxy Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
The present invention provides 4-amino-azepan-3-one protease inhibitors and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, novel intermediates of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gingival disease including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia of malignancy; and metabolic bone disease, comprising inhibiting said bone loss or exces-sive cartilage or matrix degradation by administering to a patient in need thereof a compound of the present invention.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59384500A | 2000-06-14 | 2000-06-14 | |
PCT/US2001/019062 WO2001095911A1 (en) | 2000-06-14 | 2001-06-14 | Protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2002002671A0 true AP2002002671A0 (en) | 2002-12-31 |
Family
ID=24376433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/2002/002671A AP2002002671A0 (en) | 2000-06-14 | 2001-06-14 | Protease inhibitors. |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1307204A4 (en) |
JP (1) | JP2004503502A (en) |
KR (1) | KR20030008220A (en) |
CN (1) | CN1444481A (en) |
AP (1) | AP2002002671A0 (en) |
AR (1) | AR032622A1 (en) |
AU (1) | AU2001268407A1 (en) |
BG (1) | BG107327A (en) |
BR (1) | BR0111693A (en) |
CA (1) | CA2412353A1 (en) |
CZ (1) | CZ20024086A3 (en) |
EA (1) | EA200300018A1 (en) |
EC (1) | ECSP024388A (en) |
HU (1) | HUP0301231A2 (en) |
IL (1) | IL153421A0 (en) |
MA (1) | MA25758A1 (en) |
MX (1) | MXPA02012442A (en) |
NO (1) | NO20025786L (en) |
NZ (1) | NZ522965A (en) |
OA (1) | OA12288A (en) |
PE (1) | PE20011374A1 (en) |
PL (1) | PL360508A1 (en) |
SK (1) | SK17592002A3 (en) |
WO (1) | WO2001095911A1 (en) |
ZA (1) | ZA200209808B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1231921A4 (en) * | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | Protease inhibitors |
WO2001034159A1 (en) * | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
WO2003053331A2 (en) * | 2000-11-22 | 2003-07-03 | Smithkline Beecham Corporation | Protease inhibitors |
US7709510B2 (en) | 2001-02-20 | 2010-05-04 | Chugai Seiyaku Kabushiki Kaisha | Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators |
KR100659427B1 (en) | 2001-02-20 | 2006-12-18 | 추가이 세이야쿠 가부시키가이샤 | Azoles As Malonyl-CoA Decarboxylase Inhibitors Useful As Metabolic Modulators |
EP1401453A4 (en) * | 2001-05-17 | 2005-04-06 | Smithkline Beecham Corp | Protease inhibitors |
ES2309563T3 (en) | 2003-08-01 | 2008-12-16 | Chugai Seiyaku Kabushiki Kaisha | PIPERIDINE COMPOUNDS USED AS INHIBITORS FROM MALONIL COENZIMA TO DESCARBOXYLASE. |
CA2533747C (en) * | 2003-08-01 | 2012-11-13 | Chugai Seiyaku Kabushiki Kaisha | Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
DE602004016530D1 (en) | 2003-08-01 | 2008-10-23 | Chugai Pharmaceutical Co Ltd | CYANOGUANIDIN-BASED AZOL COMPOUNDS AS MALONYL-COA DECARBOXYLASE HEMMER |
EP2719700A1 (en) | 2008-01-09 | 2014-04-16 | Amura Therapeutics Limited | Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases |
CN103275070A (en) * | 2013-05-10 | 2013-09-04 | 郑彪 | Tetracyclic compound for adjusting proliferation of mononuclear cells and application of tetracyclic compound |
US9427441B2 (en) | 2014-02-19 | 2016-08-30 | Indiana University Research And Technology Corporation | Targeting primary cilia to treat glaucoma |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ2285A1 (en) * | 1996-08-08 | 2002-12-25 | Smithkline Beecham Corp | Cysteine protease inhibitors. |
TR200101869T2 (en) * | 1998-12-23 | 2002-01-21 | Smithkline Beecham Corporation | Protease Inhibitors. |
WO2001034565A2 (en) * | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
EP1231921A4 (en) * | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | Protease inhibitors |
JP2004509083A (en) * | 2000-09-01 | 2004-03-25 | スミスクライン・ビーチャム・コーポレイション | Method of treatment |
WO2003053331A2 (en) * | 2000-11-22 | 2003-07-03 | Smithkline Beecham Corporation | Protease inhibitors |
EP1401453A4 (en) * | 2001-05-17 | 2005-04-06 | Smithkline Beecham Corp | Protease inhibitors |
-
2001
- 2001-06-14 CN CN01813500A patent/CN1444481A/en active Pending
- 2001-06-14 AP APAP/P/2002/002671A patent/AP2002002671A0/en unknown
- 2001-06-14 EA EA200300018A patent/EA200300018A1/en unknown
- 2001-06-14 KR KR1020027017045A patent/KR20030008220A/en not_active Application Discontinuation
- 2001-06-14 PE PE2001000566A patent/PE20011374A1/en not_active Application Discontinuation
- 2001-06-14 HU HU0301231A patent/HUP0301231A2/en unknown
- 2001-06-14 AU AU2001268407A patent/AU2001268407A1/en not_active Abandoned
- 2001-06-14 CZ CZ20024086A patent/CZ20024086A3/en unknown
- 2001-06-14 AR ARP010102840A patent/AR032622A1/en not_active Application Discontinuation
- 2001-06-14 IL IL15342101A patent/IL153421A0/en unknown
- 2001-06-14 PL PL36050801A patent/PL360508A1/en not_active Application Discontinuation
- 2001-06-14 EP EP01946344A patent/EP1307204A4/en not_active Withdrawn
- 2001-06-14 SK SK1759-2002A patent/SK17592002A3/en not_active Application Discontinuation
- 2001-06-14 WO PCT/US2001/019062 patent/WO2001095911A1/en active IP Right Grant
- 2001-06-14 NZ NZ522965A patent/NZ522965A/en unknown
- 2001-06-14 CA CA002412353A patent/CA2412353A1/en not_active Abandoned
- 2001-06-14 BR BR0111693-2A patent/BR0111693A/en not_active IP Right Cessation
- 2001-06-14 OA OA1200200377A patent/OA12288A/en unknown
- 2001-06-14 JP JP2002510089A patent/JP2004503502A/en active Pending
- 2001-06-14 MX MXPA02012442A patent/MXPA02012442A/en unknown
-
2002
- 2002-11-28 BG BG107327A patent/BG107327A/en unknown
- 2002-12-02 NO NO20025786A patent/NO20025786L/en not_active Application Discontinuation
- 2002-12-03 ZA ZA200209808A patent/ZA200209808B/en unknown
- 2002-12-12 EC EC2002004388A patent/ECSP024388A/en unknown
- 2002-12-13 MA MA26952A patent/MA25758A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA200300018A1 (en) | 2003-06-26 |
EP1307204A1 (en) | 2003-05-07 |
NO20025786D0 (en) | 2002-12-02 |
IL153421A0 (en) | 2003-07-06 |
SK17592002A3 (en) | 2003-05-02 |
BG107327A (en) | 2003-07-31 |
PL360508A1 (en) | 2004-09-06 |
JP2004503502A (en) | 2004-02-05 |
EP1307204A4 (en) | 2004-06-02 |
OA12288A (en) | 2003-12-12 |
KR20030008220A (en) | 2003-01-24 |
NO20025786L (en) | 2003-02-12 |
CA2412353A1 (en) | 2001-12-20 |
MA25758A1 (en) | 2003-04-01 |
CN1444481A (en) | 2003-09-24 |
ECSP024388A (en) | 2003-02-06 |
CZ20024086A3 (en) | 2003-05-14 |
ZA200209808B (en) | 2004-07-09 |
AU2001268407A1 (en) | 2001-12-24 |
NZ522965A (en) | 2004-06-25 |
MXPA02012442A (en) | 2003-04-25 |
HUP0301231A2 (en) | 2003-08-28 |
WO2001095911A1 (en) | 2001-12-20 |
PE20011374A1 (en) | 2002-04-07 |
AR032622A1 (en) | 2003-11-19 |
BR0111693A (en) | 2004-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GC0000178A (en) | Protease inhibitors | |
MY141596A (en) | Protease inhibitors | |
AP9801222A0 (en) | Proatease inhibitors. | |
NZ537853A (en) | Inhibitors of cathepsin K and related cysteine protesases of the CA clan | |
WO1999059526A3 (en) | Protease inhibitors | |
AP2002002671A0 (en) | Protease inhibitors. | |
BR9809333A (en) | Protease inhibitors | |
WO2002092563A3 (en) | Protease inhibitors | |
UY26088A1 (en) | PROTEASE INHIBITORS | |
WO2003053331A3 (en) | Protease inhibitors | |
UY26026A1 (en) | PROTEASE INHIBITORS | |
ECSP992959A (en) | BIS-AMINOMETIL CARBONYL PROTEASE INHIBITORS | |
ECSP982486A (en) | PROTEASE INHIBITORS II | |
AR021971A1 (en) | PROTEASE INHIBITORS | |
ECSP003403A (en) | PROTEASE INHIBITORS XI | |
ECSP993293A (en) | PROTEASE INHIBITORS VIII | |
UY26771A1 (en) | PROTEASE INHIBITORS | |
ECSP982481A (en) | PROTEASE INHIBITORS | |
ECSP003353A (en) | PROTEASE INHIBITORS IX | |
ECSP982493A (en) | PROTEASE INHIBITORS III | |
NZ324101A (en) | Protease inhibitors, pharmaceutical compositions and use thereof | |
AR004703A1 (en) | HYDRAZIDIL, BIS-HYDRAZIL AND BIS-AMINOMETIL-CARBONIL, PROTEASE INHIBITORS, A PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING PROTEASES, AND USE IN THE PREPARATION OF MEDICINES. |